Beyond Air Inc (XAIR): Market Cap to Revenue

Symbol and logo of brand AINostix (XAIR)

Beyond Air, Inc. (XAIR) is scaling sales of its respiratory systems through global distributors and hospital networks. The company's P/S ratio reflects the market valuation relative to revenue, which currently stands at 0.40. Equipment rentals and consumables ensure a steady stream of income. The innovative LungFit system replaces bulky gas cylinders with portable lung therapy devices.

XAIR AINostix P/S Multiple (07/04/2022 - 11/14/2026)

Analytical breakdowns for Beyond Air, Inc. (XAIR)

- share price and consensus valuation forecast:
Price Performance Chart beyondair.net|XAIR - Price Target Chart
- stock exchange capitalization data:
Market Valuation AINostix|XAIR - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Beyond Air|XAIR - Book Capitalization|Capitalization to Book Value Ratio beyondair.net|XAIR - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Beyond Air, Inc.|XAIR - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio beyondair.net|XAIR - Company Aggregate Debts|Debts to Book Capitalization AINostix|XAIR - Company Long-Term Debt|Company Short-Term Debt Beyond Air|Intermediate Coverage Ratio beyondair.net
- earnings and multiples data:
XAIR - Net Profit|Expected Net Profit Beyond Air, Inc.|XAIR - Price to Earnings Ratio|Forward Price to Earnings Multiple beyondair.net|XAIR - Price/Earnings to Growth Multiple|EV/EBITDA Multiple AINostix|XAIR - Operating profit EBITDA|Net earnings per share for the last four quarters Beyond Air|XAIR - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months beyondair.net|XAIR - Earnings per share growth in current year|Expected earnings per share growth for next year Beyond Air, Inc.
- issuer revenue and sales details:
XAIR - Revenue and Sales Volume|Company Expected Sales Volume beyondair.net|XAIR - Price-to-Revenue Ratio|Market Cap to Projected Revenue AINostix
General company analysis:XAIR Beyond Air Inc
Core merchandise of Beyond Air

Beyond Air, Inc. (XAIR) is moving toward the commercialization of its nitric oxide delivery systems, making revenue the key driver of value. This multiple compares the business's market value to its sales volume, measuring the premium the market is willing to pay per unit of revenue. Analyzing the market capitalization-to-revenue ratio allows for the identification of a stable valuation corridor for the asset. The stability of this range confirms the company's protection against devaluation shocks and the fundamental confidence of investors.

Competitors of Beyond Air, Inc.

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corporation)|Price-to-Revenue Ratio Sensus Healthcare Corp|Market Cap to Revenue Zynex Corp (ZYXI)|P/S Multiple ECOR|RBOT - Price to Sales|Price-to-Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Revenue Ratio|IRIX: Market Cap to Revenue|Intelligent Bio Solutions - Market Cap to Sales Volume|PFSA: P/S Multiple|SSKN (STRATA Skin Sciences, Inc.) - Price-to-Revenue Ratio|GCTK (GlucoTrack, Inc.) - P/S Multiple|Price to Sales nanovibronix.com NAOV|Market Cap to Revenue VERO (Venus Concept Corp)|NUWE - Price to Sales|Price-to-Revenue Ratio Aethlon Medical AEMD|Asensus Surgical Inc (ASXC) - Price to Sales|AVGR - Price-to-Revenue Ratio|BSGM (BioSig) - Market Cap to Revenue Ratio|CUTR: P/S Multiple|Market Cap to Revenue Ratio KNW|Market Cap to Revenue NARI|NVRO: Market Capitalization-to-Revenue Ratio|P/S Multiple RSLS|P/S Multiple Silk Road Medical, Inc. (SILK)